Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Contact Us


1444 Eye Street, NW, Ste. 910
Washington, DC 20005-6573

Sen. Roy Blunt
Honorary Co-Chairman

Sen. Ben Cardin
Honorary Co-Chairman

Dr. Bob Graham

In The Spotlight

Trends in Coverage and Affordability on the ACA Marketplaces

Briefing Friday, July 15, 2016

In advance of the fourth open enrollment period for health coverage under the Affordable Care Act (ACA), which begins Nov. 1, this briefing will examine who has gained coverage, who remains uninsured, and why uninsured individuals have not obtained coverage. Speakers will also discuss marketplace stability, factors driving premium trends, and the outlook for 2017 premiums. Read More

Recent Briefings

The implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) could have broad implications for physicians, health systems, health plans, consumers and others. This briefing will explore the key concerns and considerations raised during the comment period, along with possibilities and prospects for moving forward.  Read More

This briefing reviews the requirements of MACRA, including MIPS, the APMs and the choices physicians will need to make. We also examined what this means for doctor practices and health systems who employ doctors, including what the burden of quality reporting will be for these groups, what the relative impact will be for large and small practices, and how this might accelerate or slow the trend toward provider consolidation. Read More

With biosimilar biological products moving from the lab to the marketplace, key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. This discussion will provide background on current policy and regulatory issues surrounding biosimilars, and it will consider implications for the future, answering critical questions such as: What does the future of the biosimilars market hold for patients? What information do patients and their physicians need about these medicines? What role will payers play in educating health care professionals and patients?  Read More

MACRA: Stakeholder Considerations & Next Steps

Get Alliance Updates

Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds

Webcast: The Emerging Biosimilars Market

Watch the webcast of our June 20 panel discussion on biosimilar biological medications.

Read More

Copyright 1997-2016 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      Sitemap